A 66-year-old man with ischemic cardiomyopathy status post-dynamic cardiomyoplasty in 1994 and revision 2 months prior to admission presented with increasing erythema around the site of his muscle stimulator. An ultrasound of the stimulator pocket showed no fluid collection, and the patient was started on intravenous antibiotics. The ECG revealed artifactual spikes from the latissimus dorsi muscle (LDM) stimulated to contract in synchrony with cardiac systole: typical changes following dynamic cardiomyoplasty (Fig. 1 ).
Cardiomyoplasty is a surgical treatment for end-stage heart failure that is an alternative to heart transplant, whereby the LDM is pedunculated and wrapped around the heart (Fig. 2) . This wrap is then Bconditioned^by electrical stimulation to reduce fatigability, transforming the fast-twitch skeletal muscle into slow-twitch fibers similar to cardiac muscle. Dynamic cardiomyoplasty was hypothesized to improve systolic function via augmented contraction and to reduce remodeling by a girdling effect of the wrap, with most clinical benefit arising from the latter. The procedure fell out of favor in the USA, primarily due to (a) improvement in ejection fraction but neutral effect on invasive hemodynamics, 2 (b) lack of longterm mortality improvement 2 and (c) Medtronic withdrawal of their cardiomyostimulators in the late 1990s, leaving surgeons without an FDA-approved device.
